(May 11 18:44) World.einnews.com
… therapy in solid tumor indications
Singapore-based AUM Biosciences has entered … evaluate AUM001, the company’s novel, highly selective MNK1/2 … remains a critical need for novel clinical therapies that can further …
You can find the original article
here